Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia.

Authors :: Alshukairi, Abeer N.
Jincun Zhao
Al-Mozaini, Maha A.
Yanqun Wang
Dada, Ashraf
Baharoon, Salim A.
Alfaraj, Sara
Ahmed, Waleed A.
Enani, Mushira A.
Elzein, Fatehi E.
Eltayeb, Nazik
Layqah, Laila
El-Saed, Aiman
Bahaudden, Husam A.
Haseeb, Abdul
El-Kafrawy, Sherif A.
Hassan, Ahmed M.
Siddiq, Najlaa A.
Alsharif, Ibtihaj
Qushmaq, Isamel
Source :: Emerging Infectious Diseases; May2021, Vol. 27 Issue 5, p1472-1476, 5p
Publication Year :: 2021
Abstract: Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection. [ABSTRACT FROM AUTHOR]

Subjects :: MERS coronavirus
CORONAVIRUS diseases
ANTIBODY formation
LONGEVITY
VACCINE development

Full Text Access

Tools